CPC A61K 9/5153 (2013.01) [A61K 9/0019 (2013.01)] | 17 Claims |
1. A method of treating traumatic brain injury in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of nanoparticles consisting essentially of poly(lactic-co-glycolic acid) (PLGA); wherein the nanoparticles are free of any attached or embedded peptide, antigen, or other active agent; and the nanoparticles are administered intravenously.
|